Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer

Epidermal growth factor receptor (EGFR) is overexpressed in >60% of non-small cell lung cancer (NSCLC) cases. In combination with radiotherapy or chemotherapy, first-line treatments with antibodies against EGFR, including cetuximab and necitumumab, have demonstrated benefits by increasing overall...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Avilés-Salas, Alejandro, Muñiz-Hernández, Saé, Maldonado-Martínez, Héctor Aquiles, Chanona-Vilchis, José G., Ramírez-Tirado, Laura-Alejandra, HernáNdez-Pedro, Norma, Dorantes-Heredia, Rita, RuíZ-Morales, José Manuel, Motola-Kuba, Daniel, Arrieta, Oscar
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5351342/
https://ncbi.nlm.nih.gov/pubmed/28356978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5512
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi